BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Treatment
29 results:

  • 1. Increased expression of the pathological O-glycosylated form of oncofetal fibronectin in the multidrug resistance phenotype of cancer cells.
    Reis JSD; Santos MARDC; da Costa KM; Freire-de-Lima CG; Morrot A; Previato JO; Previato LM; da Fonseca LM; Freire-de-Lima L
    Matrix Biol; 2023 Apr; 118():47-68. PubMed ID: 36882122
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Improvement of cytotoxicity of mitoxantrone and daunorubicin by candidone, tephrosin, and bavachinin.
    Darzi S; Mirzaei SA; Elahian F; Peymani A; Rahmani B; Pishkhan Dibazar S; Shirian S; Shakeri Chaleshtori L; Aali E
    Mol Biol Rep; 2021 Nov; 48(11):7105-7111. PubMed ID: 34564803
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant gastric cancer SGC7901/DDP Cells.
    Zhan D; Ni T; Wang H; Lv M; Sunagawa M; Liu Y
    Anticancer Agents Med Chem; 2022; 22(2):270-279. PubMed ID: 34053427
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Jianpi Yangwei decoction promotes apoptosis and suppresses proliferation of 5-fluorouracil resistant gastric cancer cells in vitro and in vivo.
    Tang H; Huang W; Yang Q; Lin Y; Chen Y; Shu P
    BMC Complement Med Ther; 2020 Nov; 20(1):337. PubMed ID: 33167958
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Ribophorin II potentiates P-glycoprotein- and abcg2-mediated multidrug resistance via activating ERK pathway in gastric cancer.
    Zhang H; Jiang H; Zhang H; Liu J; Hu X; Chen L
    Int J Biol Macromol; 2019 May; 128():574-582. PubMed ID: 30710584
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. DIFFERENT CONCENTRATIONS OF SIJUNZI DECOCTION INHIBIT PROLIFERATION AND INDUCE APOPTOSIS OF HUMAN gastric cancer SGC-7901 SIDE POPULATION.
    Qian J; Li J; Jia J; Jin X; Yu D; Guo C; Xie B; Qian L
    Afr J Tradit Complement Altern Med; 2016; 13(4):145-156. PubMed ID: 28852730
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The role of GLI2-abcg2 signaling axis for 5Fu resistance in gastric cancer.
    Yu B; Gu D; Zhang X; Liu B; Xie J
    J Genet Genomics; 2017 Aug; 44(8):375-383. PubMed ID: 28847472
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. DS-8201a, a new HER2-targeting antibody-drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2-positive gastric cancer T-DM1 resistance.
    Takegawa N; Nonagase Y; Yonesaka K; Sakai K; Maenishi O; Ogitani Y; Tamura T; Nishio K; Nakagawa K; Tsurutani J
    Int J Cancer; 2017 Oct; 141(8):1682-1689. PubMed ID: 28677116
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancer.
    Yu B; Gu D; Zhang X; Li J; Liu B; Xie J
    Oncotarget; 2017 Apr; 8(16):27412-27427. PubMed ID: 28404967
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. abcg2 confers promotion in gastric cancer through modulating downstream CRKL in vitro combining with biostatistics mining.
    Wang J; Yunyun Z; Wang L; Chen X; Zhu Z
    Oncotarget; 2017 Jan; 8(3):5256-5267. PubMed ID: 28029654
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Role and mechanism research on reversal of 5-fluorouracil resistance by epigallocatechin gallate in gastric cancer drug-resistance cells lines SGC-7901/5-FU].
    Tang H; Zhang X; Cui S; Wang J; Ruan Q; Huang Y; Yang D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1170-1175. PubMed ID: 27781257
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Antibody validation and scoring guidelines for abcg2 immunohistochemical staining in formalin-fixed paraffin-embedded colon cancer tissue.
    Cederbye CN; Palshof JA; Hansen TP; Duun-Henriksen AK; Linnemann D; Stenvang J; Nielsen DL; Brünner N; Viuff BM
    Sci Rep; 2016 Jun; 6():26997. PubMed ID: 27257141
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical Predictors of Venetoclax Pharmacokinetics in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patients: a Pooled Population Pharmacokinetic Analysis.
    Jones AK; Freise KJ; Agarwal SK; Humerickhouse RA; Wong SL; Salem AH
    AAPS J; 2016 Sep; 18(5):1192-1202. PubMed ID: 27233802
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Combining abcg2 Inhibitors with IMMU-132, an Anti-Trop-2 Antibody Conjugate of SN-38, Overcomes Resistance to SN-38 in Breast and gastric cancers.
    Chang CH; Wang Y; Zalath M; Liu D; Cardillo TM; Goldenberg DM
    Mol Cancer Ther; 2016 Aug; 15(8):1910-9. PubMed ID: 27207776
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Synergic effect between 5‑fluorouracil and celecoxib on hypoxic gastric cancer cells.
    Zhang XQ; Sun XE; Liu WD; Feng YG; Zhang HM; Shi LH; Sun XN; Li YQ; Gao ZX
    Mol Med Rep; 2015 Feb; 11(2):1160-6. PubMed ID: 25351347
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induced cell-specific drug transporters with acquired cisplatin resistance in cisplatin sensitive cancer cells.
    Gotovdorj T; Lee E; Lim Y; Cha EJ; Kwon D; Hong E; Kim Y; Oh MY
    J Korean Med Sci; 2014 Sep; 29(9):1188-98. PubMed ID: 25246735
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Genistein-inhibited cancer stem cell-like properties and reduced chemoresistance of gastric cancer.
    Huang W; Wan C; Luo Q; Huang Z; Luo Q
    Int J Mol Sci; 2014 Feb; 15(3):3432-43. PubMed ID: 24573253
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. S100P enhances the chemosensitivity of human gastric cancer cell lines.
    Zhao X; Bai Z; Wu P; Zhang Z
    Cancer Biomark; 2013; 13(1):1-10. PubMed ID: 23736016
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-alpha alter the expression and function of abcg2 in cervix and gastric cancer cells.
    Mosaffa F; Kalalinia F; Lage H; Afshari JT; Behravan J
    Mol Cell Biochem; 2012 Apr; 363(1-2):385-93. PubMed ID: 22193459
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters.
    Mi YJ; Liang YJ; Huang HB; Zhao HY; Wu CP; Wang F; Tao LY; Zhang CZ; Dai CL; Tiwari AK; Ma XX; To KK; Ambudkar SV; Chen ZS; Fu LW
    Cancer Res; 2010 Oct; 70(20):7981-91. PubMed ID: 20876799
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.